News

We provide the latest news
from the world of economics and finance

24 March
Pre-Market Earnings Report for March 25, 2025 : ATAT, RUM, CRMD, CSIQ, SMTI, ATOS, XFOR, PAVM, ACCS, CNM, MKC, PHGE

The following companies are expected to report earnings prior to market open on 03/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.

Atour Lifestyle Holdings Limited (ATAT)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $0.30. ATAT reported earnings of $0.21 per share for the same quarter a year ago; representing a a increase of 42.86%.Rumble Inc. (RUM)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.13. RUM reported earnings of $-0.14 per share for the same quarter a year ago; representing a a decrease of -7.14%.CorMedix Inc. (CRMD)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $0.17. CRMD reported earnings of $-0.26 per share for the same quarter a year ago; representing a a decrease of -165.38%.Canadian Solar Inc. (CSIQ)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.21. CSIQ reported earnings of $-0.02 per share for the same quarter a year ago; representing a a increase of 950.00%.Sanara MedTech Inc. (SMTI)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.19. SMTI reported earnings of $-0.03 per share for the same quarter a year ago; representing a a increase of 533.33%.Atossa Therapeutics, Inc. (ATOS)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.06. ATOS reported earnings of $-0.06 per share for the same quarter a year ago; representing a The "days to cover" for this stock exceeds 16 days.X4 Pharmaceuticals, Inc. (XFOR)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 5 analysts that follow the stock is $-0.17. XFOR reported earnings of $-0.1 per share for the same quarter a year ago; representing a a increase of 70.00%.PAVmed Inc. (PAVM)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.60. PAVM reported earnings of $-1.57 per share for the same quarter a year ago; representing a a decrease of -61.78%.ACCESS Newswire Inc. (ACCS)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $0.17. ACCS reported earnings of $0.08 per share for the same quarter a year ago; representing a a increase of 112.50%.Core & Main, Inc. (CNM)is reporting for the quarter ending January 31, 2025. The consensus earnings per share forecast from the 3 analysts that follow the stock is $0.36. CNM reported earnings of $0.34 per share for the same quarter a year ago; representing a a increase of 5.88%.McCormick & Company, Incorporated (MKC)is reporting for the quarter ending February 28, 2025. The consensus earnings per share forecast from the 6 analysts that follow the stock is $0.64. MKC reported earnings of $0.63 per share for the same quarter a year ago; representing a a increase of 1.59%.BiomX Inc. (PHGE)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 1 analyst that follows the stock is $-1.65. PHGE reported earnings of $-0.8 per share for the same quarter a year ago; representing a a increase of 106.25%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

х
Risk warning: Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
Contact usCollapse